Description
These cells are manufactured with optimized methods to ensure a high-quality product with superior viability, purity, and functionality.
Utilization of our cell products can yield a faster time-to-market as less time will be spent on sample preparation and leaving our clients to focus on more technically challenging endpoint assays.
Researchers can receive PBMCs and other fresh material less than 24 hours after collection. These cell isolations can either be shipped fresh overnight for immediate use or cryopreserved for future scheduled work.
- PBMCs can be prepared from a variety of source matrices: vacutainer collection, buffy coat, leukopak and more
- Further processing performed, including RBC lysis, washing, and counting
- Aliquoting by cell count
Patient samples can also be prospectively collected to meet study-specific inclusion and exclusion criteria. All collections are conducted under IRB-approved protocols, and all donors sign informed consent forms where applicable. Samples are fully characterized and come complete with demographic and medical data, as recorded on case report forms at the time of collection.